These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22512563)

  • 1. From fungus to pharmaceuticals--the chemistry of statins.
    McPherson PA
    Mini Rev Med Chem; 2012 Oct; 12(12):1250-60. PubMed ID: 22512563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of HMG-CoA Reductase: Current and Future Prospects.
    Singh N; Tamariz J; Chamorro G; Medina-Franco JL
    Mini Rev Med Chem; 2009 Oct; 9(11):1272-83. PubMed ID: 19929805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural mechanism for statin inhibition of HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Istvan ES
    Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins via interaction with the lipid bilayer: A combined approach.
    Penkauskas T; Zentelyte A; Ganpule S; Valincius G; Preta G
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183306. PubMed ID: 32302615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins.
    Murphy C; Deplazes E; Cranfield CG; Garcia A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase modulator: toward age- and sex-personalized medicine.
    Pallottini V
    Expert Opin Ther Pat; 2015; 25(10):1079-83. PubMed ID: 26135220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitors of HMG CoA reductase: new modes of action, new indications?].
    Essig M; Vrtovsnik F; Friedlander G
    Therapie; 2000; 55(1):43-9. PubMed ID: 10860000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving LDL-C target levels: the role of statins.
    Lablanche JM
    Curr Med Res Opin; 2001; 16(4):285-95. PubMed ID: 11268713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of HMG-CoA reductase inhibitors. Medical-chemical aspects of statins].
    Stark H
    Pharm Unserer Zeit; 2003; 32(6):464-71. PubMed ID: 14639827
    [No Abstract]   [Full Text] [Related]  

  • 12. [Statins--the panacea of the turn of the century?].
    Lubiszewska B; Ruzyłło W
    Pol Arch Med Wewn; 2004 May; 111(5):617-24. PubMed ID: 15508815
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives on the cardioprotective effects of statins.
    Luo JD; Chen AF
    Curr Med Chem; 2003 Aug; 10(16):1593-601. PubMed ID: 12871130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squalene epoxidase as hypocholesterolemic drug target revisited.
    Chugh A; Ray A; Gupta JB
    Prog Lipid Res; 2003 Jan; 42(1):37-50. PubMed ID: 12467639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia.
    da Silva VB; Taft CA; Silva CH
    J Phys Chem A; 2008 Mar; 112(10):2007-11. PubMed ID: 18044855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of nonstatin cholesterol lowering agents.
    Trapani L; Segatto M; Ascenzi P; Pallottini V
    IUBMB Life; 2011 Nov; 63(11):964-71. PubMed ID: 21990243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin pharmacology may have important clinical implications.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():2, 5. PubMed ID: 12608150
    [No Abstract]   [Full Text] [Related]  

  • 19. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia.
    Seiki S; Frishman WH
    Cardiol Rev; 2009; 17(2):70-6. PubMed ID: 19367148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.